Adhering to current clinical guidance supports evidence-based assessment, informs decision-making, and helps reduce complications in patients living with Alzheimer’s disease. Regular review of the latest recommendations and guidance assists clinicians in improving evaluation and management, which supports better patient outcomes.
Today's rundown features clinical guidance on Alzheimer’s disease and dementia. We divided the following guidance documents into two groups. The dementia category may overlap with Alzheimer’s, but the Alzheimer's group contains guidance exclusive to the disease. All guidelines featured today were published within the past five years.
Alzheimer’s Disease Guidance
- Use of Tau PET Imaging in Alzheimer’s Disease
- Society of Nuclear Medicine and Molecular Imaging (SNMMI), European Association of Nuclear Medicine (EANM)
- March 2026
- Use of Blood-Based Biomarkers in the Diagnostic Workup of Suspected Alzheimer’s Disease Within Specialized Care Settings
- Alzheimer’s Association
- July 2025
- Diagnostic Evaluation, Testing, Counseling, and Disclosure of Suspected Alzheimer’s Disease and Related Disorders
- Alzheimer’s Association
- December 2024
- Diagnosis and Staging of Alzheimer’s Disease
- Alzheimer’s Association
- June 2024
Dementia Guidance
- Dementia
- American College of Radiology
- May 2025
- Assessment, Diagnosis, Care and Support for People with Dementia and Their Carers
- Scottish Intercollegiate Guidelines Network
- November 2023
Check out other neurology clinical guidance and sign up for alerts to stay informed on the latest published guidelines and insights.